Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124474162 | 12447416 | 2 | F | 2008 | 20160718 | 20160608 | 20160725 | EXP | US-DSJP-DSU-2016-104896 | DAIICHI | 0.00 | Y | 0.00000 | 20160725 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124474162 | 12447416 | 1 | PS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | Oral | 40 MG, QD | Y | 21286 | 40 | MG | TABLET | QD | |||||
124474162 | 12447416 | 2 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 5 MG, UNK | Y | 21286 | 5 | MG | TABLET | |||||||
124474162 | 12447416 | 3 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 10 MG, UNK | Y | 21286 | 10 | MG | TABLET | |||||||
124474162 | 12447416 | 4 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | 10 MG, QD EVENING | 0 | 10 | MG | TABLET | QD | ||||||
124474162 | 12447416 | 5 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | 10 MG, UNK | 0 | 10 | MG | CAPSULE | ||||||||
124474162 | 12447416 | 6 | C | DIAZIDE /00007602/ | HYDRALAZINE HYDROCHLORIDE | 1 | Oral | 37.5MG/25MG , BID | 0 | 1 | DF | CAPSULE | BID | ||||||
124474162 | 12447416 | 7 | C | CALCIUM + VIT D | CALCIUMVITAMIN D | 1 | Oral | 600MG/200MG , BID | 0 | 1 | DF | TABLET | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124474162 | 12447416 | 1 | Hypertension |
124474162 | 12447416 | 4 | Multiple allergies |
124474162 | 12447416 | 5 | Multiple allergies |
124474162 | 12447416 | 6 | Hypertension |
124474162 | 12447416 | 7 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124474162 | 12447416 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124474162 | 12447416 | Anal pruritus | |
124474162 | 12447416 | Cholecystectomy | |
124474162 | 12447416 | Haemorrhoids | |
124474162 | 12447416 | Irritable bowel syndrome | |
124474162 | 12447416 | Malabsorption |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124474162 | 12447416 | 1 | 20080121 | 20150812 | 0 |